NIOX
NEUTRALNIOX Group Plc Announces Director Dealings
The healthcare company has announced changes to its major shareholdings.
NIOX Group
70.20GBX
-1.13%
Market Cap
293.31M
Volume
99.01k
14% of avg
P/E Ratio
22.57
EPS (TTM)
3.11
Beta
0.43
Day Range
69.40p - 71.60p
52 Week Range
53.40p70.20p80.00p
70.20p
Upcoming Events
30 September 2025
Interim results for H1 2025
High Impact Event
Q4 2025
Launch of the NIOX PRO device
High Impact Event
NIOX
NEUTRALNIOX Group Plc Announces Holding(s) in Company
The healthcare company has announced a change in its major shareholding structure.
NIOX
NEUTRALNIOX Group Plc Announces PDMR/PCA Shareholding
The healthcare company has announced a transaction by a person closely associated with a senior executive.
NIOX
VERY GOODNIOX Group Delivers Strong H1 2025 Performance
The medical device company reports strong first-half performance, with revenue up 20% and Adjusted EBITDA rising 30%. The business saw robust growth in both its clinical and research divisions.
NIOX
NEUTRALNIOX Group Announces Director Share Issuance
The healthcare company has issued new shares to its Non-Executive Chairman as part of a bonus plan.
NIOX
NEUTRALNIOX Group Plc Announces Holding Change
The healthcare company has announced a change in shareholding, with Rathbones Investment Management Ltd increasing its stake to over 10%.
NIOX
NEUTRALNIOX Group Plc Announces Holding(s) in Company
The healthcare company has announced a change in shareholding, with Rathbones Investment Management Ltd now holding 8.695% of the voting rights.
NIOX
NEUTRALNIOX Group Announces Director Dealings
The healthcare company has announced changes to its director shareholdings.
NIOX
NEUTRALNIOX Group Plc Announces Holding Change
The healthcare company has announced a change in shareholding, with Danske Bank A/S now holding 2.99% of the voting rights.
NIOX
NEUTRALNIOX Group Announces Change of Adviser
The healthcare company has appointed a new sole broker.